Esteban Masuda

Esteban Masuda

Company: Rigel Pharmaceuticals

Job title: Executive VP, Science and Research


Leveraging the Spleen Tyrosine Kinase (SYK) Pathways to Target Inflammatory Signaling in Multiple Diseases with Fostamatinib 2:30 pm

Treating antibody-mediated platelet destruction with the first kinase inhibitor approved for immune thrombocytopenia Discussing late-stage clinical trial development for autoimmune hemolytic anemia (antibody-mediated RBC destruction) Weaponizing against COVID: discussing the use of fostamatinib in late phase clinical trials for the treatment of hospitalized adults with COVID-19Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.